LUNG Cancer
Real HOPE For Lung Cancer Patients
Lung cancer is the most commonly diagnosed cancer, accounting for the most cancer deaths each year. It is very hard to detect in its early stages and may take years to grow.
If you have cancer, it is as unique as your fingerprint. We offer a functional profiling ANALYSIS that measures, in the laboratory, how your lung cancer cells respond to various drugs BEFORE you receive them.
This test helps select the most effective and least toxic drug regimen for your lung cancer.
At the Nagourney Cancer Institute, we believe every cancer patient deserves a treatment plan tailored to their unique biology.

Lung
cancer
Lung cancer can form anywhere in the lung tissue, but more than 90 percent of these cancers are thought to arise in the epithelial cells which line the airways.
The most common forms of this cancer are:
Small cell lung cancer (SCLC)
is almost always associated with smoking and comprises less than 20 percent of all lung cases diagnosed.
It often starts in the bronchi (near the center of the chest) and it tends to spread throughout the body fairly early in the course of the disease.
Non-small cell lung cancer (NSCLC) accounts for 80 – 90 percent of all lung cancers.
There are three major sub-types of NSCLC:
Squamous cell carcinoma tends to be found in the central portions of the lung and is typically associated with smoking.
Adenocarcinoma is usually found in the outer part of the lung.
Large-cell carcinoma typically grow and spread quickly and can be found in any part of the lung.
Lung mesothelioma is found in the lining of the lungs. Typically this type of cancer is due to asbestos exposure and it may take up to 50 years for the symptoms to appear.